Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
JOURNAL ARTICLE
Alina Zubarevich, Marcin Szczechowicz, Konstantin Zhigalov, Philipp Marx, Alexander Lind, Rolf Alexander Jánosi, Tienush Rassaf, Sharaf-Eldin Shehada, Rizwan Malik, Markus Kamler, Matthias Thielmann, Bastian Schmack, Arjang Ruhparwar, Alexander Weymann, Daniel Wendt
Background: We sought to evaluate the outcomes of transapical transcatheter mitral valve replacement in patients with degenerated mitral bioprostheses or failed mitral ring annuloplasty and high surgical risk for redo mitral valve procedure. Methods: Between August 2012 and December 2020, 41 consecutive high-risk patients underwent transcatheter mitral 'valve-in-valve' (TM-ViV, n=25) or 'valve-in-ring' (TM-ViR, n=16) implantation at our institution. All procedures were performed in a hybrid operating theater using the SAPIEN XT/3™ or the DIRECT FLOW MEDICAL™ prostheses...
September 2021: Annals of Cardiothoracic Surgery
#22
REVIEW
Michael Mack, John D Carroll, Vinod Thourani, Sreekanth Vemulapalli, John Squiers, Pratik Manandhar, G Michael Deeb, Wayne Batchelor, Howard C Herrmann, David J Cohen, George Hanzel, Thomas Gleason, Ajay Kirtane, Nimesh Desai, Kim Guibone, Karen Hardy, Joan Michaels, J Michael DiMaio, Barbara Christensen, Susan Fitzgerald, Carole Krohn, Ralph G Brindis, Fred Masoudi, Joseph Bavaria
Data for nearly all patients undergoing transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) with an approved device in the United States is captured in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. All data submitted for TEER or TMVR between 2014 and March 31, 2020, are reported. A total of 37,475 patients underwent a mitral transcatheter procedure, including 33,878 TEER and 3,597 TMVR. Annual procedure volumes for TEER have increased from 1,152 per year in 2014 to 10,460 per year in 2019 at 403 sites and for TMVR from 84 per year to 1,120 per year at 301 centers...
December 7, 2021: Journal of the American College of Cardiology
#23
JOURNAL ARTICLE
Michael Mack, John D Carroll, Vinod Thourani, Sreekanth Vemulapalli, John Squiers, Pratik Manandhar, G Michael Deeb, Wayne Batchelor, Howard C Herrmann, David J Cohen, George Hanzel, Thomas Gleason, Ajay Kirtane, Nimesh Desai, Kim Guibone, Karen Hardy, Joan Michaels, J Michael DiMaio, Barbara Christensen, Susan Fitzgerald, Carole Krohn, Ralph G Brindis, Fred Masoudi, Joseph Bavaria
Data for nearly all patients undergoing transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) with an approved device in the United States is captured in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. All data submitted for TEER or TMVR between 2014 and March 31, 2020, are reported. A total of 37,475 patients underwent a mitral transcatheter procedure, including 33,878 TEER and 3,597 TMVR. Annual procedure volumes for TEER have increased from 1,152 per year in 2014 to 10,460 per year in 2019 at 403 sites and for TMVR from 84 per year to 1,120 per year at 301 centers...
October 21, 2021: Annals of Thoracic Surgery
#24
JOURNAL ARTICLE
Rashmi Nedadur, Bo Wang, Wendy Tsang
BACKGROUND: One of the surgical options available for ischemic mitral regurgitation (MR) is mitral valve repair but is limited by recurrent regurgitation as it is experienced by a significant percentage of patients and has a negative impact on patient outcomes. Efforts to model and identify predictors of recurrent MR rely on complicated echocardiographic and clinical measurements that are subjective and not routinely collected. AIMS: Kachroo et al. approached this problem in a unique way by using the STS database and machine learning (ML) to develop models that predict recurrent MR or death at 1 year...
January 2022: Journal of Cardiac Surgery
#25
REVIEW
Ellen W Richter, Islam M Shehata, Hamdy M Elsayed-Awad, Matthew A Klopman, Sujatha P Bhandary
Mitral regurgitation (MR) is one of the most frequently encountered types of valvular heart disease in the United States. Patients with significant MR (moderate-to-severe or severe) undergoing noncardiac surgery have an increased risk of perioperative cardiovascular complications. MR can arise from a diverse array of causes that fall into 2 broad categories: primary (diseases intrinsic to the valvular apparatus) and secondary (diseases that disrupt normal valve function via effects on the left ventricle or mitral annulus)...
March 2022: Seminars in Cardiothoracic and Vascular Anesthesia
#26
Y K Su, B L Harrison, E C Dunne, M Calfon Press, J M Moriarty
Percutaneous mitral valve (MV) repair using MitraClip requires large-caliber venous access. We describe a patient with a ligated inferior vena cava due to an Adams-DeWeese clip placed 50 years prior, who had progressive shortness of breath and lower extremity symptoms secondary to severe mitral regurgitation and chronic iliocaval deep venous thrombosis. Due to comorbidities, MitraClip was recommended over surgery for MV repair. Caval luminal gain was required to facilitate endovascular access for the MitraClip system...
November 2021: Annals of Vascular Surgery
#27
JOURNAL ARTICLE
Aikaterini Papamanoli, Tahmid Rahman, Andreas P Kalogeropoulos, Zeena Lobo, Paul Diggs, Anne Hamik, George Psevdos
BACKGROUND: Transcatheter edge-to-edge mitral valve repair using the MitraClip device is increasingly used for high surgical risk patients with severe mitral regurgitation (MR). Previous guidelines for infective endocarditis prophylaxis prior to dental procedures focused on high-risk patients, but without explicit recommendation for MitraClip recipients. We believe this could be the first reported case to identify Streptococcus oralis as the causative organism. CASE PRESENTATION: An 87-year-old male with severe MR treated with two MitraClip devices three months prior to index admission, presented with worsening malaise and intermittent chills on a background of multiple comorbid conditions...
August 28, 2021: BMC Infectious Diseases
#28
Brian D McCauley, Howard C Herrmann, Tiffany Chen, Saif Anwaruddin
We describe the case of an 83-year-old man with a history of ischemic cardiomyopathy and severe secondary mitral regurgitation. This case highlights the role of transcatheter edge-to-edge repair with the MitraClip in the management of symptomatic functional mitral regurgitation in a surgically unfavorable patient. ( Level of Difficulty: Advanced. ).
March 2021: JACC. Case reports
#29
JOURNAL ARTICLE
Fei Xu, Emily L Johnson, Chenglong Wang, Arian Jafari, Cheng-Hau Yang, Michael S Sacks, Adarsh Krishnamurthy, Ming-Chen Hsu
The left ventricle of the heart is a fundamental structure in the human cardiac system that pumps oxygenated blood into the systemic circulation. Several valvular conditions can cause the aortic and mitral valves associated with the left ventricle to become severely diseased and require replacement. However, the clinical outcomes of such operations, specifically the postoperative ventricular hemodynamics of replacing both valves, are not well understood. This work uses computational fluid-structure interaction (FSI) to develop an improved understanding of this effect by modeling a left ventricle with the aortic and mitral valves replaced with bioprostheses...
March 2021: Mechanics Research Communications
#30
JOURNAL ARTICLE
Nolwazi Mokitimi, Katherina van der Donck, Hlamatsi Moutlana, Palesa Motshabi Chakane
BACKGROUND: Peri-operative morbidity and mortality are increased in patients with rheumatic heart disease. Pre-operative risk stratification is imperative for optimisation and a better outcome. METHODS: This was a descriptive, retrospective, contextual study. A consecutive convenience sampling method was used. Eighty-nine patients who underwent mitral valve surgery at Charlotte Maxeke Johannesburg Academic Hospital between January 2014 and December 2015 were enrolled...
September 2021: Cardiovascular Journal of Africa
#31
JOURNAL ARTICLE
Faizus Sazzad, Ong Zhi Xian, Ashlynn Ler, Chang Guohao, Kang Giap Swee, Theo Kofidis
BACKGROUND: CORKNOT® facilitates a reduction in cardiopulmonary bypass (CPB) time, aortic cross clamp (ACC) time and operative time, but reported to be associated with other complications. We aim to quantify the incidence of valvular complications related to CORKNOT® and determine the feasibility of its use between different valvular surgeries. METHODS: Patients who underwent heart valve repair or replacement surgery via the use of automated titanium suture fasteners (CORKNOT®) in a tertiary care hospital were included in the study...
June 7, 2021: Journal of Cardiothoracic Surgery
#32
JOURNAL ARTICLE
Ayse Baysal, Gonul Sagiroglu, Mevlut Dogukan, Ismail Ozkaynak
OBJECTIVE: To determine the possible risk factors associated with hepatic dysfunction during open-heart surgeries. METHODS: After excluding 71 patients, 307 patients with possible low and moderate cardiac risk who underwent either coronary artery bypass graft surgery (CABG) (n=176) or valve repair surgery (mitral valve, mitral and aortic valves and/or tricuspid valve) (n=131) were investigated prospectively during a 6-month period. Hyperbilirubinemia is defined as an occurrence of a plasma total bilirubin concentration >34 µmol/L (2 mg/dL) in any measurement during the postoperative period; the patients were divided into groups with or without postoperative hyperbilirubinemia...
April 1, 2021: Brazilian Journal of Cardiovascular Surgery
#33
REVIEW
Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly, Patrick T O'Gara, Joshua A Beckman, Glenn N Levine, Sana M Al-Khatib, Anastasia Armbruster, Kim K Birtcher, Joaquin Ciggaroa, Anita Deswal, Dave L Dixon, Lee A Fleisher, Lisa de Las Fuentes, Federico Gentile, Zachary D Goldberger, Bulent Gorenek, Norrisa Haynes, Adrian F Hernandez, Mark A Hlatky, José A Joglar, W Schuyler Jones, Joseph E Marine, Daniel Mark, Latha Palaniappan, Mariann R Piano, Erica S Spatz, Jacqueline Tamis-Holland, Duminda N Wijeysundera, Y Joseph Woo
No abstract text is available yet for this article.
August 2021: Journal of Thoracic and Cardiovascular Surgery
#34
JOURNAL ARTICLE
Radwa Abdullah Elbelbesy, Ahmed Mohsen Elsawah, Ahmed Shafie Ammar, Hazem Abdelmohsen Khamis, Islam Elsayed Shehata
BACKGROUND: Our aim was to assess safety and efficacy outcomes at 1 year after MitraClip for percutaneous mitral valve repair in patients with severe mitral regurgitation. Twenty consecutive patients with significant MR (GIII or GIV) were selected according to the AHA/ACC guidelines from June 2016 to June 2019 and underwent percutaneous edge-to-edge mitral valve repair using MitraClip with a whole 1 year follow-up following the procedure. The primary acute safety endpoint was a 30-day freedom from any of the major adverse events (MAEs) or rehospitalization for heart failure...
May 3, 2021: Egyptian Heart Journal: EHJ
#35
JOURNAL ARTICLE
Anan A Abu Rmilah, Mahmoud A Tahboub, Adham K Alkurashi, Suhaib A Jaber, Asil H Yagmour, Deema Al-Souri, Bradley R Lewis, Vuyisile T Nkomo, Patricia J Erwin, Guy S Reeder
Aims: Percutaneous mitral balloon valvotomy PMBV is an acceptable alternative to Mitral valve surgery for patients with mitral stenosis. The purpose of this study was to explore the immediate results of PMBV with respect to echocardiographic changes, outcomes, and complications, using a meta -analysis approach. Methods: MEDLINE, and EMBASE databases were searched (01/2012 to 10/2018) for original research articles regarding the efficacy and safety of PMBV. Two reviewers independently screened references for inclusion and abstracted data including article details and echocardiographic parameters before and 24-72 h after PMBV, follow-up duration, and acute complications...
April 2021: IJC Heart & Vasculature
#36
JOURNAL ARTICLE
Yujiro Hayashi, Yoshitsugu Nakamura, Takahisa Hirano, Yujiro Ito, Takashi Watanabe
Minimally invasive mitral valve repair, recently, has become an alternative procedure to conventional mitral valve surgery, given its clinical benefits. Understanding the learning curve of a new procedure is important prior to its introduction. This study aimed to evaluate the learning curve for minimally invasive mitral valve repair and safety during the start-up period. The first 100 consecutive patients who underwent isolated minimally invasive mitral valve repair for mitral valve regurgitation were evaluated...
March 27, 2021: Heart and Vessels
#37
REVIEW
Asif Neil Mohammed, Sofia A Lifgren, Michael Fabbro, Pankaj Jain
US Food and Drug Administration approval of the edge-to-edge clip repair device (MitraClip; Abbott Laboratories, Abbott Park, IL) in 2013 led to wide adoption of the device for treatment of severe primary mitral regurgitation in patients unsuitable for surgery. Demonstration of favorable outcomes in the setting of secondary mitral regurgitation by the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial in 2019 provided an additional impetus to the transcatheter mitral interventional program...
May 2021: Journal of Cardiothoracic and Vascular Anesthesia
#38
Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly
AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline...
February 2, 2021: Journal of the American College of Cardiology
#39
Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly
No abstract text is available yet for this article.
February 2, 2021: Journal of the American College of Cardiology
#40
JOURNAL ARTICLE
Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly
No abstract text is available yet for this article.
February 2, 2021: Circulation
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
